"10.1371_journal.pone.0141098","plos one","2015-11-06T00:00:00Z","Viviane E Bernedo Paredes; Hans-Georg Buchholz; Martin Gartenschläger; Markus Breimhorst; Mathias Schreckenberger; Konrad J Werhahn","Department of Neurology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany; Department of Nuclear Medicine, University Medical Center of the Johannes Gutenberg University, Mainz, Germany","Conceived and designed the experiments: VEBP HGB MG MS KJW. Performed the experiments: VEBP HGB MG MS KJW. Analyzed the data: VEBP HGB MG MB MS KJW. Contributed reagents/materials/analysis tools: VEBP HGB MG MB MS KJW. Wrote the paper: VEBP HGB MG MB MS KJW.","The authors have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Viviane E. Bernedo received speaking honoraria from UCB. Dr. Hans-Georg Buchholz, Dr. Martin Gartenschläger, Markus Breimhorst and Dr. Mathias Schreckenberger have no conflicts of interest. Dr. Konrad J. Werhahn was head of the Epilepsy Unit in our institution during the study. Since 2012, he has been employed by UCB Pharma. He received consultation/advisory board/speaking honoraria from UCB, Pfizer, Eisai, Janssen-Cilag, and Desitin. UCB also supported clinical research for which he served as primary investigator (IIT trial). The indicated competing interests do not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","11","Viviane E Bernedo Paredes","VEBP",6,TRUE,5,5,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
